All patients were followed for an additional 6 months after the end of treatment for the determination of sustained virologic response.
Kõiki patsiente jälgiti 6 kuu jooksul peale ravi lõppemist, et teha kindlaks püsiva viroloogilise ravivastuse olemasolu.